NASDAQ · Financial Statements

Aclaris Therapeutics, Inc. (ACRS) Financial Statements

$3.28 NASDAQ: ACRS Market Cap $482.81M

Aclaris Therapeutics, Inc. most recently reported annual revenue of $8.0M, a net loss of $65.0M. Revenue grew at an average annual rate of 5.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$30.0M$31.0M$19.0M$8.0M
Operating Profit$-90.0M$-90.0M$-97.0M$-142.0M$-76.0M
Net Profit$-91.0M$-87.0M$-88.0M$-132.0M$-65.0M
EPS$-1.60$-1.33$-1.27$-1.71$-0.53
Op Margin-1327.1%-302.0%-311.6%-758.2%-975.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$251.0M$255.0M$197.0M$220.0M$160.0M
Total Liabilities$54.0M$57.0M$40.0M$65.0M$57.0M
Cash$27.0M$45.0M$40.0M$25.0M$20.0M
Borrowings$1.0M$1.0M$0$0$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-52.0M$-68.0M$-78.0M$-20.0M$-47.0M
Investing Cash Flow$-168.0M$12.0M$45.0M$-70.0M$48.0M
Financing Cash Flow$-2.0M$0$0$0$-6.0M
Net Cash Flow$5.0M$18.0M$-5.0M$-15.0M$-5.0M
Free Cash Flow$-52.0M$-68.0M$-80.0M$-20.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.19
EV / EBITDA-9.32
FCF Yield-8.64%
Quick Ratio3.46
Interest Coverage—
Return 1Y226.19%
Return 3Y-44.37%
Return 5Y-64.09%

Aclaris Therapeutics, Inc. (ACRS) financials — frequently asked questions

What is Aclaris Therapeutics, Inc.'s annual revenue?

Aclaris Therapeutics, Inc. (ACRS) reported annual revenue of $8.0M in its most recent fiscal year.

What is Aclaris Therapeutics, Inc.'s net profit?

Aclaris Therapeutics, Inc. (ACRS) reported a net loss of $65.0M in its most recent fiscal year.

What is ACRS EV/EBITDA?

Aclaris Therapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -9.32. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
ACRS Overview ACRS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.